Company intelligence / Profile preview

Mable

San Francisco, California, United Statesmeetmable.com ↗

Ownership: Private
Development stage: Other

Overview

Mable operates an active digital healthcare platform that delivers personalized migraine care using genomics data. The service includes customized plans with acute/preventative medications, vitamins, anti-nausea meds, and counseling. The company has raised $3.2 million in seed funding and serves patients via its online clinic. No clinical trial results are reported as it does not develop drugs.

Therapeutic areas: Neurology
Modalities: Digital health platform
Industry: Non-Academic Healthcare

Partnerships

No major pharmaceutical or biotech partnerships disclosed in available sources.

Beyond the preview

Go deeper on Mable.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mable.

Explore the full profile